Squarepoint Ops LLC Charles River Laboratories International, Inc. Call Options Transaction History

Squarepoint Ops LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $413,512 - $539,638	-2,200 Reduced 43.14%	2,900 $571,000
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $20,639 - $26,873	-100 Reduced 1.92%	5,100 $1.05 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $1.24 Million - $1.67 Million	-6,100 Reduced 53.98%	5,200 $1.41 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $1.86 Million - $2.7 Million	11,300 New	11,300 $2.67 Million

694

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.29B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.